Jingyu Zhang

机构：Tianjin University of Technology and Education, Nanchang University, Shandong University, Zhejiang Cancer Hospital, Second Affiliated Hospital of Nanchang University, Drug Discovery Laboratory (Norway), Shenyang The Fourth Hospital of People, Weihai Science and Technology Bureau, Hangzhou Cancer Hospital, Inner Mongolia University of Technology, Zhejiang University · ORCID：0000-0003-4820-577X

发表论文 59 篇 · 总被引 895 次 · h-index 18

代表论文

• Structural Feature Analyzation Strategies toward Discovery of Orally Bioavailable PROTACs of Bruton’s Tyrosine Kinase for the Treatment of Lymphoma (2022 · Journal of Medicinal Chemistry · 被引 54)
• Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy (2024 · Journal of Medicinal Chemistry · 被引 24)
• Dual roles of FAK in tumor angiogenesis: A review focused on pericyte FAK (2023 · European Journal of Pharmacology · 被引 24)
• Formin‐like 2 promotes angiogenesis and metastasis of colorectal cancer by regulating the EGFL6 / CKAP4 / ERK axis (2023 · Cancer Science · 被引 23)
• The Causal Relationship between PCSK9 Inhibitors and Malignant Tumors: A Mendelian Randomization Study Based on Drug Targeting (2024 · Genes · 被引 20)
• Fibrinogen: A new player and target on the formation of pre-metastatic niche in tumor metastasis (2025 · Critical Reviews in Oncology/Hematology · 被引 18)